]. S. Bertani, P. Pineau, S. Loli, J. Moura, M. Zimic et al., An Atypical Age-Specific Pattern of Hepatocellular Carcinoma in Peru: A Threat for Andean Populations, PLoS ONE, vol.37, issue.6, p.67756, 2013.
DOI : 10.1371/journal.pone.0067756.t001
URL : https://hal.archives-ouvertes.fr/hal-01356600

A. Marchio, S. Bertani, T. Rojas-rojas, F. Doimi, B. Terris et al., A Peculiar Mutation Spectrum Emerging from Young Peruvian Patients with Hepatocellular Carcinoma, PLoS ONE, vol.2012, issue.5, p.114912, 2014.
DOI : 10.1371/journal.pone.0114912.s004
URL : https://hal.archives-ouvertes.fr/hal-01239684

E. Bender, Developing world: Global warning, Nature, vol.106, issue.7502, pp.64-65, 2014.
DOI : 10.1038/509S64a

J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, International Journal of Cancer, vol.13, issue.5, pp.359-386, 2015.
DOI : 10.1002/ijc.29210

J. M. Henderson, M. Sherman, A. Tavill, M. Abecassis, G. Chejfec et al., AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement, AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement, pp.243-250, 2003.
DOI : 10.1080/13651820310015833

J. N. Vauthey, E. Dixon, E. K. Abdalla, W. S. Helton, T. M. Pawlik et al., Pretreatment assessment of hepatocellular carcinoma: expert consensus statement, Pretreatment assessment of hepatocellular carcinoma: expert consensus statement, pp.289-299, 2010.
DOI : 10.1111/j.1477-2574.2010.00181.x

E. L. Kaplan and P. Meier, Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-481, 1958.
DOI : 10.1214/aoms/1177731566

D. R. Cox, Regression Models and Life-Tables, J. R. Stat. Soc. B, vol.34, pp.187-220, 1972.
DOI : 10.1007/978-1-4612-4380-9_37

_. T. Hpb, Terminology Committee of the International Hepato-Pancreato-Biliary Association, [ 1 8 _ T D $ D I F F ] The Brisbane 2000 terminology of hepatic anatomy and resections, pp.333-339, 2000.

Y. Zhou, X. Lei, L. Wu, X. Wu, D. Xu et al., Outcomes of hepatectomy for noncirrhotic hepatocellular carcinoma: A systematic review, Surgical Oncology, vol.23, issue.4, pp.136-142, 2014.
DOI : 10.1016/j.suronc.2014.11.001

D. Dindo, N. Demartines, and P. A. Clavien, Classification of Surgical Complications, Annals of Surgery, vol.240, issue.2, pp.240-205, 2004.
DOI : 10.1097/01.sla.0000133083.54934.ae

J. M. Llovet, C. Brú, and J. Bruix, Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification, Seminars in Liver Disease, vol.19, issue.03, pp.329-338, 1999.
DOI : 10.1055/s-2007-1007122

A. Forner, M. E. Reig, C. R. De-lope, and J. Bruix, Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects, Seminars in Liver Disease, vol.30, issue.01, pp.61-74, 2010.
DOI : 10.1055/s-0030-1247133

]. K. Okuda, T. Ohtsuki, H. Obata, M. Tomimatsu, N. Okazaki et al., Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients, Cancer, vol.4, issue.4, pp.918-928, 1985.
DOI : 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E

S. Chevret, J. C. Trinchet, D. Mathieu, A. A. Rached, M. Beaugrand et al., A new prognostic classification for predicting survival in patients with hepatocellular carcinoma, Journal of Hepatology, vol.31, issue.1, pp.31-133, 1999.
DOI : 10.1016/S0168-8278(99)80173-1

T. W. Leung, A. M. Tang, B. Zee, W. Y. Lau, P. B. Lai et al., Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system, Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the liver Italian program staging system, pp.1760-1769, 2002.
DOI : 10.1002/cncr.10384

N. Kokudo, K. Hasegawa, M. Akahane, H. Igaki, N. Izumi et al., Evidence-based clinical practice guidelines for hepatocellular carcinoma, Hepatol. Res, pp.45-123, 2015.

M. Kudo, O. Matsui, N. Izumi, H. Lijima, M. Kadoya et al., Surveillance and Diagnostic Algorithm for Hepatocellular Carcinoma Proposed by the Liver Cancer Study Group of Japan: 2014 Update, Oncology, vol.87, issue.s1, pp.7-21, 2014.
DOI : 10.1159/000368141

J. Bruix, M. Sherman, J. M. Llovet, M. Beaugrand, R. Lencioni et al., Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver, J. Hepatol, pp.35-421, 2001.

J. Bruix and M. Sherman, Management of hepatocellular carcinoma, Hepatology, vol.35, issue.5, pp.1208-1236, 2005.
DOI : 10.1002/hep.20933

J. Shindoh, A. Andreou, T. A. Aloia, G. Zimmitti, G. Y. Lauwers et al., Microvascular Invasion Does Not Predict Long-Term Survival in Hepatocellular Carcinoma up to 2??cm: Reappraisal of the Staging System for Solitary Tumors, Annals of Surgical Oncology, vol.10, issue.4, pp.1223-1229, 2012.
DOI : 10.1245/s10434-012-2739-y

A. Guglielmi, A. Ruzzenente, S. Conci, A. Valdegamberi, M. Vitali et al., Hepatocellular carcinoma: surgical perspectives beyond Article No~e00052 http This is an open access article under the CC BY-NC-ND license

T. Livraghi, G. Brambilla, C. Carnaghi, M. A. Tommasini, and G. Torzili, Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?, Journal of Surgical Oncology, vol.8, issue.7, pp.868-876, 2010.
DOI : 10.1002/jso.21733

G. Tsoulfas, A. Mekras, P. Agorastou, and D. Kiskinis, Surgical treatment for large hepatocellular carcinoma: does size matter?, ANZ Journal of Surgery, vol.6, issue.7-8, pp.510-517, 2012.
DOI : 10.1111/j.1445-2197.2012.06079.x

M. A. Trovato, A. Pesce, M. Sofia, A. Montineri, A. Basile et al., Is BCLC algorithm useful in clinical practice? Study on 164 HCC patients, Hepatogastroenterology, vol.60, pp.1742-1745, 2013.

S. Leoni, F. Piscaglia, I. Serio, E. Terzi, I. Pettinari et al., Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group, Digestive and Liver Disease, vol.46, issue.6, pp.46-549, 2014.
DOI : 10.1016/j.dld.2014.02.012

M. Hernández-guerra, A. Hernández-camba, J. Turnes, L. M. Ramos, L. Arranz et al., Application of the Barcelona Clinic Liver Cancer therapeutic strategy and impact on survival, United Eur, Gastroenterol. J, vol.3, pp.284-293, 2015.

L. B. Alexandrov, S. Nik-zainal, D. C. Wedge, S. A. Aparicio, S. Behjati et al., Signatures of mutational processes in human cancer, Nature, vol.27, issue.7463, pp.415-421, 2013.
DOI : 10.1038/nature12477

J. C. Nault and A. Villanueva, Intratumor Molecular and Phenotypic Diversity in Hepatocellular Carcinoma, Clinical Cancer Research, vol.21, issue.8, pp.1786-1788, 2015.
DOI : 10.1158/1078-0432.CCR-14-2602

M. Schlageter, L. M. Terracciano, S. D. Angelo, and P. Sorrentino, Histopathology of hepatocellular carcinoma, World Journal of Gastroenterology, vol.20, issue.43, pp.15955-15964, 2014.
DOI : 10.3748/wjg.v20.i43.15955

N. Méndez-sánchez, E. Ridruejo, A. Alves-de-mattos, N. C. Chávez-tapia, R. Zapata et al., Latin American Association for the Study of the Liver (LAASL) clinical practice guidelines: Management of hepatocellular carcinoma, Ann. Hepatol, pp.13-17, 2014.

S. E. Kim, H. C. Lee, K. M. Kim, Y. S. Lim, Y. H. Chung et al., Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center, The Korean Journal of Hepatology, vol.17, issue.2, pp.17-113, 2011.
DOI : 10.3350/kjhep.2011.17.2.113

J. J. Zhao, T. Yan, H. Zhao, J. G. Zhou, Z. Huang et al., Evaluation of eight different clinical staging systems associated with overall survival of Chinese patients with hepatocellular carcinoma

M. Omata, L. A. Lesmana, R. Tateishi, P. J. Chen, S. M. Lin et al., Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma, Hepatology International, vol.123, issue.Suppl 2, pp.439-474, 2010.
DOI : 10.1007/s12072-010-9165-7

K. Okuda, Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants, Journal of Gastroenterology and Hepatology, vol.12, issue.4
DOI : 10.1046/j.1440-1746.2001.02610.x

P. Farmer, J. Frenk, F. M. Knaul, L. N. Shulman, G. Alleyne et al., Expansion of cancer care and control in countries of low and middle income: a call to action, The Lancet, vol.376, issue.9747, pp.1186-1193, 2010.
DOI : 10.1016/S0140-6736(10)61152-X

S. B. Edge and C. C. Compton, The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM, Annals of Surgical Oncology, vol.17, issue.6, pp.17-1471, 2010.
DOI : 10.1245/s10434-010-0985-4

K. M. Kee, J. H. Wang, C. Y. Lin, C. C. Wang, Y. F. Cheng et al., Validation of the 7th Edition TNM Staging System for Hepatocellular Carcinoma: An Analysis of 8,828 Patients in a Single Medical Center, Digestive Diseases and Sciences, vol.21, issue.9, pp.58-2721, 2013.
DOI : 10.1007/s10620-013-2716-8

A. No~e00052-http, This is an open access article under the CC BY-NC-ND license